CD44 and cancer: Thus, various strategies are evolving for treatments of cancer that focus on HA and CD44, including interference with the HA-CD44v signaling, by either targeting drugs to CD44v [50], targeting drugs to the HA matrix [51], or interfering with HA-CD44v interactions [52].